Filing Details

Accession Number:
0000791908-17-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-23 10:31:13
Reporting Period:
2017-03-21
Filing Date:
2017-03-23
Accepted Time:
2017-03-23 10:31:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638479 M. Thomas Burns C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Vp, Finance & Chief Financial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2017-03-21 2,598 $5.40 6,555 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,390 Indirect by 401(k)
Footnotes
  1. Indirect ownership includes shares acquired from a 401(k) match accumulated during 2016 and purchased on 1/26/2017, deemed not reportable.
  2. Shares sold on the open market to satisfy the taxes required to be withheld in connection with the vesting of the shares in a non-discretionary transaction pursuant to the reporting person's agreement under the Company's incentive plan.
  3. Shares sold at multiple prices between $5.40 and $5.4004 with a weighted average sale price of $5.400337.
  4. Includes unvested RSUs previously reported on Table I.